Verity Asset Management’s Fulgent Genetics FLGT Stock Holding History

Verity Asset Management’s Portfolio FLGT Stock Details FLGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-2,558	Closed	-$236K	–	205
2021 Q2	$236K	Buy	+2,558	New	+$204K	0.13%	193

Other funds holding FLGT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Verity Asset Management's FLGT Position: Q3 2021 in Review

Verity Asset Management sold out of Fulgent Genetics (FLGT) in Q3 2021, closing a stake of 2,558 shares — an estimated $236K sold.

Verity Asset Management first reported a position in FLGT in Q2 2021 and held it in 1 quarter. The position peaked at $236K in Q2 2021. 268 funds tracked by Wall St. Rank hold FLGT as of Q3 2021.

Verity Asset Management reported no remaining Fulgent Genetics position as of Q3 2021 after selling out during the quarter.
Verity Asset Management sold 2,558 Fulgent Genetics shares in Q3 2021, an estimated $236K.
Verity Asset Management first reported a position in Fulgent Genetics in Q2 2021 and held it in 1 quarter.
Verity Asset Management's Fulgent Genetics position peaked at $236K in Q2 2021.
268 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2021.

Based on Verity Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.